Milan, Lombardy, Italy Innogest Capital appeared to be the VC, which was created in 2006. The company was established in Europe in Italy. The main department of described VC is located in the Milan.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Innogest Capital, startups are often financed by Digital Magics, Italian Angels for Growth, Atlante Ventures. The meaningful sponsors for the fund in investment in the same round are Invitalia Ventures, Ysios Capital, Atlante Ventures. In the next rounds fund is usually obtained by TLcom Capital Partners, Ysios Capital, Tribeca Venture Partners.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Italy. Among the most popular portfolio startups of the fund, we may highlight CornerJob, Cascaad (CircleMe), sardex.net. Among the most successful fund investment fields, there are Apps, Medical.
This organization was formed by Claudio Giuliano, Marco Pinciroli. Besides them, we counted 6 critical employees of this fund in our database.
The fund is generally included in 2-6 deals every year. The important activity for fund was in 2016. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2013. This Innogest Capital works on 22 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.
Related Funds
Funds with similar focus
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BetaGlue Technologies | $11M | 20 Jul 2022 | Milano, Lombardia, Italy | ||
GreenBone Ortho | $11M | 13 Apr 2021 | Italy, Emilia-Romagna, Italy | ||
Everli | $100M | 29 Mar 2021 | Milan, Lombardy, Italy | ||
Anaconda BioMed | $23M | 04 Dec 2019 | Catalonia | ||
Newronika | $9M | 25 Sep 2019 | Italy, Lombardy | ||
Renovacor | $11M | 15 Aug 2019 | Philadelphia, Pennsylvania, United States | ||
armadioverde | $626K | 02 Aug 2019 | Lombardy | ||
armadioverde | $590K | 01 May 2019 | Lombardy | ||
armadioverde | $590K | 01 Dec 2018 | Lombardy |
– European online grocery shopping marketplace Everli raised $100m in Series C funding.
– The round was led by Verlinvest and joined by Luxor, DN Capital, C4 Ventures and Convivialité Ventures, FITEC (part of Fondo Italiano d’Investimento), 360 Capital, Innogest and DIP.
– The company plans to use the injection of capital to accelerate growth and further expand its international footprint.
– MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round.
– MedLumics’ optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
– This round was led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II.
– MedLumics is now ready to initiate first in-human regulatory clinical studies and automate scalable product manufacturing.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BetaGlue Technologies | $11M | 20 Jul 2022 | Milano, Lombardia, Italy | ||
GreenBone Ortho | $11M | 13 Apr 2021 | Italy, Emilia-Romagna, Italy | ||
Everli | $100M | 29 Mar 2021 | Milan, Lombardy, Italy | ||
Anaconda BioMed | $23M | 04 Dec 2019 | Catalonia | ||
Newronika | $9M | 25 Sep 2019 | Italy, Lombardy | ||
Renovacor | $11M | 15 Aug 2019 | Philadelphia, Pennsylvania, United States | ||
armadioverde | $626K | 02 Aug 2019 | Lombardy | ||
armadioverde | $590K | 01 May 2019 | Lombardy | ||
armadioverde | $590K | 01 Dec 2018 | Lombardy |
